Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secalonic acid D reduced the percentage of side populations by down-regulating the expression of ABCG2

Published:2013-06 Issue:11 Volume:85 Page:1619-1625
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Hu Ya-peng,Tao Li-yang,Wang Fang,Zhang Jian-ye,Liang Yong-ju,Fu Li-wu

Funder

State Key Laboratory of Oncology in South China

National Key Research and Development Program of China

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference35 articles.

1. Cancer stem cell niche: the place to be;Borovski;Cancer Res,2011

2. Targeting cancer stem cells: a new therapy to cure cancer patients;Hu;Am J Cancer Res,2012

3. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells;Ho;Cancer Res,2007

4. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo;Goodell;J Exp Med,1996

5. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype;Zhou;Nat Med,2001

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using nanotechnology to progress the utilization of marine natural products in combating multidrug resistance in cancer: A prospective strategy;Journal of Biochemical and Molecular Toxicology;2024-05-20

2. Natural products for combating multidrug resistance in cancer;Pharmacological Research;2024-04

3. ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?;Biomedicines;2024-01-05

4. Machine learning-identified stemness features and constructed stemness-related subtype with prognosis, chemotherapy, and immunotherapy responses for non-small cell lung cancer patients;Stem Cell Research & Therapy;2023-09-07

5. Clinical relevance of stem cells in lung cancer;World Journal of Stem Cells;2023-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3